default author photo

Gottfried E. Konecny

University of California, Los Angeles (UCLA) - UCLA Medical Center

SCHOLARLY PAPERS

3

DOWNLOADS

155

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Genomic Alterations, Molecularly Targeted Therapy, and Survival: A Real-World Endometrial Cancer Molecularly Targeted Therapy Consortium Cohort Study

Number of pages: 33 Posted: 14 Aug 2024
Duke University, University of North Carolina (UNC) at Chapel Hill - Division of Gynecologic Oncology, affiliation not provided to SSRN, Siteman Cancer Center, affiliation not provided to SSRN, Duke University, University of Oklahoma - University of Oklahoma Health Sciences Center, Duke University, University of Cincinnati - University of Cincinnati Medical Center, University of California, Los Angeles (UCLA) - UCLA Medical Center, University of Virginia, University of Alabama at Birmingham, Columbia University - Irving Medical Center, University of Colorado Denver, Inova Health System - Inova Fairfax Hospital, The James Comprehensive Cancer Center - Division of Gynecologic Oncology, affiliation not provided to SSRN, University of Oklahoma - University of Oklahoma Health Sciences Center, University of Cincinnati, City of Hope National Medical Center, Columbia University - Irving Medical Center, Johns Hopkins University, Johns Hopkins University, Duke University - Medical Center and New York University (NYU) - NYU Langone Health
Downloads 76 (837,727)

Abstract:

Loading...

endometrial cancer, genomic alterations, targeted therapy, survival

2.

Racial and Ethnic Differences and Clinical Outcomes of Patients with High Tumor Mutational Burden, High Microsatellite Instability, and Mismatch Repair Deficiency: Real-World Data from the Multi-Institutional Endometrial Cancer Molecularly Targeted Therapy Consortium (Ecmt2)

Number of pages: 29 Posted: 01 May 2025
New York University (NYU) - NYU Langone Health, Duke University, affiliation not provided to SSRN, New York University (NYU) - NYU Langone Health, Duke University - Duke Cancer Institute, Duke University - Duke Cancer Institute, University of Oklahoma - University of Oklahoma Health Sciences Center, University of Cincinnati - University of Cincinnati Medical Center, affiliation not provided to SSRN, Siteman Cancer Center, University of Alabama at Birmingham, Columbia University - Irving Medical Center, University of Colorado Denver, University of Pennsylvania, University of California, Los Angeles (UCLA) - UCLA Medical Center, affiliation not provided to SSRN, University of North Carolina (UNC) at Chapel Hill - Division of Gynecologic Oncology, New York University (NYU) - NYU Langone Health and New York University (NYU) - NYU Langone Health
Downloads 41 (1,183,237)

Abstract:

Loading...

Endometrial cancer, tumor mutational burden, microsatellite instability, mismatch repair deficiency

3.

Platinum-Free Interval and Response to Platinum Retreatment or Lenvatinib/Pembrolizumab in Patients with Recurrent Endometrial Cancer: A Real-World Endometrial Cancer Molecularly Targeted Therapy Consortium Cohort Study

Number of pages: 19 Posted: 02 Dec 2024
affiliation not provided to SSRN, affiliation not provided to SSRN, Duke University, Duke University - Duke University Hospital, The James Comprehensive Cancer Center - Division of Gynecologic Oncology, University of North Carolina (UNC) at Chapel Hill - Division of Gynecologic Oncology, Allegheny Health Network, New York University (NYU) - NYU Langone Health, University of Pennsylvania, Allegheny Health Network, affiliation not provided to SSRN, University of Oklahoma - Stephenson Cancer Center, affiliation not provided to SSRN, New York University (NYU) - NYU Langone Health, Siteman Cancer Center, University of Oklahoma - University of Oklahoma Health Sciences Center, University of Alabama at Birmingham, University of Colorado Denver, affiliation not provided to SSRN, University of Cincinnati - University of Cincinnati Medical Center, University of California, Los Angeles (UCLA) - UCLA Medical Center, affiliation not provided to SSRN, Duke University and affiliation not provided to SSRN
Downloads 38 (1,249,711)

Abstract:

Loading...

Platinum-free interval, Endometrial Cancer